Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation

被引：34
|
作者：
Inada, A
Nakanishi, T
Tokuda, H
Nishina, H
Iwashima, A
Sharma, OP
机构：
[1] KYOTO PREFECTURAL UNIV MED, KAMIGYO KU, KYOTO 607, JAPAN
[2] INDIAN VET RES INST, BIOCHEM LAB, REG STN, PALAMPUR 176061, HIMACHAL PRADES, INDIA
来源：
PLANTA MEDICA | 1995年 / 61卷 / 06期
关键词：
D O I：
10.1055/s-2006-959371
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
To search for possible antitumor promoters, inhibitory effects of lantadenes and related triterpenoids from Lantana camara L. (Verbenaceae) on Epstein-Barr virus activation, were tested. The substitutions on the carboxylic acid through an ester bond might play an important role in the activity.
引用
收藏
页码：558 / 559
页数：2
相关论文
共 50 条
  • [1] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
    Sacau, EP
    Estévez-Braun, A
    Ravelo, AG
    Ferro, EA
    Tokuda, H
    Mukainaka, T
    Nishino, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
  • [2] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
    Koyama, J
    Morita, I
    Tagahara, K
    Ogata, M
    Mukainaka, T
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 2001, 170 (01) : 15 - 18
  • [3] 3-epicabraleabydroxylactone and other triterpenoids from camellia oil and their inhibitory effects on Epstein-Barr virus activation
    Akihisa, T
    Tokuda, H
    Ukiya, M
    Suzuki, T
    Enjo, F
    Koike, K
    Nikaido, T
    Nishino, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (01) : 153 - 156
  • [4] Inhibitory effects on Epstein-Barr virus activation of anthraquinones: Correlation with redox potentials
    Koyama, J
    Tagahara, K
    Osakai, T
    Tsujino, Y
    Tsurumi, S
    Nishino, H
    Tokuda, H
    [J]. CANCER LETTERS, 1997, 115 (02) : 179 - 183
  • [5] Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation
    Rahman, S
    Fukamiya, N
    Ohno, N
    Tokuda, H
    Nishino, H
    Tagahara, K
    Lee, KH
    Okano, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (04) : 675 - 677
  • [6] Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
    Koyama, J
    Morita, I
    Tagahara, K
    Osakai, T
    Hotta, H
    Yang, MX
    Mukainaka, T
    Nishino, H
    Tokuda, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (09) : 1214 - 1216
  • [7] Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products
    Akihisa, T
    Hamasaki, Y
    Tokuda, H
    Ukiya, M
    Kimura, Y
    Nishino, H
    [J]. JOURNAL OF NATURAL PRODUCTS, 2004, 67 (03): : 407 - 410
  • [8] Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation
    Uesato, S
    Taniuchi, K
    Kumagai, A
    Nagaoka, Y
    Seto, R
    Hara, Y
    Tokuda, H
    Nishino, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (12) : 1448 - 1450
  • [9] Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids
    Koyama, Junko
    Morita, Izumi
    Kobayashi, Norihiro
    Konoshima, Takao
    Takasaki, Midori
    Osakai, Toshiyuki
    Tokuda, Harukuni
    [J]. CANCER LETTERS, 2008, 263 (01) : 61 - 66
  • [10] Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
    Yiu, Ching-Yi
    Chen, Shih-Ying
    Chang, Li-Kwan
    Chiu, Ya-Fang
    Lin, Tsuey-Pin
    [J]. MOLECULES, 2010, 15 (10) : 7115 - 7124
12345